CARLSBAD, Calif.—October 25, 2012 (MARKET WIRE)-- International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) (“ISCO” or “the Company”) a California-based biotechnology company focused on therapeutic and research products, today announced that its subsidiary, Lifeline Cell Technology (LCT), will begin selling products through Fisher Scientific, Inc.’s (“Fisher Scientific”) online catalogue as an Encompass Preferred Supplier.
Typically large pharmaceutical companies buy research supplies and products using preferred supplier agreements. Fisher Scientific is the world’s largest such supplier to the life science industry with over 350,000 customers and $12 Billion in annual sales. Their third party e-catalog sales have grown from $26 million in 2006 to $424 million in 2011 and represent a promising new sales channel for Lifeline Cell Technology’s cell and media products.
Dr. Simon Craw, ISCO’s Executive Vice President of Business Development explained, “This is a tremendous opportunity and a testament to the high quality of Life Line Cell Technology’s products. By working with Fisher Scientific, LCT will be able to reach many more customers that we would otherwise not be able to reach. One of the biggest challenges we faced was the ability to sell into pharmaceutical companies that have preferred supplier agreements. Our inclusion in the Fisher e-catalogs and Encompass Preferred Suppliers list, not only validates LCT’s focus on delivering high quality products but also means these products can now be purchased much more easily by scientists working at the some of the world’s largest life science companies.”
Post a Comment